Günkan Ahmet, Ferreira Marcio Yuri, Bocanegra-Becerra Jhon E, Pehlivan Umur Anil, Vilardo Marina, Semione Gabriel, Batista Sávio, Ferreira Christian, Serulle Yafell, Yardimcioglu Ismail, Bertani Raphael, Ciccio Gabriele, Jabbour Pascal
Department of Radiology, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey.
Department of Neurosurgery, Lenox Hill Hospital, New York, NY, US.
Neurosurg Rev. 2024 Dec 27;48(1):7. doi: 10.1007/s10143-024-03155-9.
In recent years, the application of robotic assistance in diagnostic and therapeutic endovascular neurointerventional procedures has gained notable attention. In this systematic review and meta-analysis, we aim to evaluate the feasibility, safety, and current indications of robotic-assisted neurointerventions and to assess the degree of robotic assistance and reasons for unplanned manual conversion from robotic assistance.
We searched Medline, Scopus, Web of Science, and Cochrane Library databases following PRISMA guidelines and included studies with ≥ 4 patients reporting on robotic-assisted neurointerventions. We analyzed outcomes including technical success, manual conversion, procedure-related complications, morbidity, and mortality with a random-effects meta-analysis. We also identified causes of manual conversion and conducted subanalyses by procedure type and robotic system.
Thirteen studies, comprising 538 robotic-assisted neurointerventions, were included. Procedures were primarily diagnostic cerebral angiograms (n = 348), cerebral aneurysm embolizations (n = 127), and carotid artery stenting (n = 37). The CorPath GRX (Corindus) robotic system was employed in the majority of cases (n = 355). Across all studies, the technical success rate was 93%, and the procedure-related complication rate was 0.7%. Manual steps were necessary in all cases due to inherent procedural requirements. Unplanned manual conversion from robotic assistance was necessary in 7% of cases. Further analysis of failures identified challenging anatomies, loss of working length, and mechanical failures as the most common reasons.
This systematic review and meta-analysis found that, with a certain degree of manual assistance, robotic-assisted neurointervention is highly feasible, safe, and capable of performing DCA, CAS, and therapeutic neurointerventions that can be executed with a single microcatheter involving simple coiling, stent-assisted coiling, and flow diverter embolization. However, unplanned manual conversion is not uncommon. Improvements in working length and mechanical parts, including the cassette robotic arm and console, as well as CorPath GRX compatibility with 0.035-inch wires, may reduce the rates of manual conversion for current indications. Nonetheless, technical adaptations are essential to broaden the scope of therapeutic neurointervention indications.
近年来,机器人辅助在诊断性和治疗性血管内神经介入手术中的应用受到了显著关注。在本系统评价和荟萃分析中,我们旨在评估机器人辅助神经介入的可行性、安全性和当前适应证,并评估机器人辅助的程度以及非计划从机器人辅助转为手动操作的原因。
我们按照PRISMA指南检索了Medline、Scopus、Web of Science和Cochrane图书馆数据库,并纳入了报告机器人辅助神经介入且患者≥4例的研究。我们采用随机效应荟萃分析来分析技术成功率、手动转换、手术相关并发症、发病率和死亡率等结果。我们还确定了手动转换的原因,并按手术类型和机器人系统进行了亚组分析。
纳入了13项研究,共538例机器人辅助神经介入手术。手术主要包括诊断性脑血管造影(n = 348)、脑动脉瘤栓塞术(n = 127)和颈动脉支架置入术(n = 37)。大多数病例(n = 355)采用了CorPath GRX(Corindus)机器人系统。在所有研究中,技术成功率为93%,手术相关并发症发生率为0.7%。由于手术本身的要求,所有病例都需要手动步骤。7%的病例需要非计划从机器人辅助转为手动操作。对失败情况的进一步分析发现,具有挑战性的解剖结构、工作长度丢失和机械故障是最常见的原因。
本系统评价和荟萃分析发现,在一定程度的手动辅助下,机器人辅助神经介入是高度可行、安全的,并且能够进行诊断性脑血管造影、颈动脉支架置入术以及使用单个微导管进行的治疗性神经介入,包括单纯弹簧圈栓塞、支架辅助弹簧圈栓塞和血流导向装置栓塞。然而,非计划的手动转换并不罕见。工作长度和机械部件(包括盒式机器人手臂和控制台)的改进,以及CorPath GRX与0.035英寸导丝的兼容性,可能会降低当前适应证的手动转换率。尽管如此,技术改进对于扩大治疗性神经介入适应证的范围至关重要。